Novolog Pharm (Israel) Market Value
| NVLG Stock | 169.90 0.50 0.30% |
| Symbol | Novolog |
Novolog Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novolog Pharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novolog Pharm.
| 12/23/2022 |
| 12/12/2024 |
If you would invest 0.00 in Novolog Pharm on December 23, 2022 and sell it all today you would earn a total of 0.00 from holding Novolog Pharm Up 1966 or generate 0.0% return on investment in Novolog Pharm over 720 days. Novolog Pharm is related to or competes with Bezeq Israeli, Nova, Enlight Renewable, Tadiran Hldg, and Azrieli. Novolog Ltd operates as a health logistics company in Israel More
Novolog Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novolog Pharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novolog Pharm Up 1966 upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.49 | |||
| Information Ratio | 0.1206 | |||
| Maximum Drawdown | 11.46 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 4.31 |
Novolog Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novolog Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novolog Pharm's standard deviation. In reality, there are many statistical measures that can use Novolog Pharm historical prices to predict the future Novolog Pharm's volatility.| Risk Adjusted Performance | 0.1386 | |||
| Jensen Alpha | 0.3555 | |||
| Total Risk Alpha | 0.039 | |||
| Sortino Ratio | 0.1614 | |||
| Treynor Ratio | (43.24) |
Novolog Pharm Up Backtested Returns
Novolog Pharm appears to be very steady, given 3 months investment horizon. Novolog Pharm Up has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Novolog Pharm, which you can use to evaluate the volatility of the firm. Please exercise Novolog Pharm's Risk Adjusted Performance of 0.1386, mean deviation of 1.43, and Downside Deviation of 1.49 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Novolog Pharm holds a performance score of 14. The company secures a Beta (Market Risk) of -0.0082, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Novolog Pharm are expected to decrease at a much lower rate. During the bear market, Novolog Pharm is likely to outperform the market. Please check Novolog Pharm's value at risk, downside variance, and the relationship between the maximum drawdown and potential upside , to make a quick decision on whether Novolog Pharm's current price movements will revert.
Auto-correlation | -0.65 |
Very good reverse predictability
Novolog Pharm Up 1966 has very good reverse predictability. Overlapping area represents the amount of predictability between Novolog Pharm time series from 23rd of December 2022 to 18th of December 2023 and 18th of December 2023 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novolog Pharm Up price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Novolog Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 100.9 |
Novolog Pharm Up lagged returns against current returns
Autocorrelation, which is Novolog Pharm stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novolog Pharm's stock expected returns. We can calculate the autocorrelation of Novolog Pharm returns to help us make a trade decision. For example, suppose you find that Novolog Pharm has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Novolog Pharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novolog Pharm stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novolog Pharm stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novolog Pharm stock over time.
Current vs Lagged Prices |
| Timeline |
Novolog Pharm Lagged Returns
When evaluating Novolog Pharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novolog Pharm stock have on its future price. Novolog Pharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novolog Pharm autocorrelation shows the relationship between Novolog Pharm stock current value and its past values and can show if there is a momentum factor associated with investing in Novolog Pharm Up 1966.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Novolog Stock
Novolog Pharm financial ratios help investors to determine whether Novolog Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novolog with respect to the benefits of owning Novolog Pharm security.